SCHEMBL4386662

SCHEMBL4386662

Cc1nc(-c2ccccc2O)no1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 2/20 0.68
SENP8 Q96LD8 2/20 0.68
SENP7 Q9BQF6 2/20 0.68
SENP6 Q9GZR1 2/20 0.68
CHUK O15111 2/20 0.53
TXNRD1 Q16881 2/20 0.53
NOX4 Q9NPH5 2/20 0.53
L3MBTL1 Q9Y468 1/20 0.50
PDK2 Q15119 1/20 0.50
SMN1; SMN2 Q16637 4/20 0.49
ALDH1A1 P00352 2/20 0.49
HSD17B10 Q99714 4/20 0.48
MAPT P10636 4/20 0.48
NPC1 O15118 3/20 0.48
KMT2A Q03164 3/20 0.48
KDM4E B2RXH2 2/20 0.48
MEN1 O00255 2/20 0.48
HPGD P15428 2/20 0.48
RAB9A P51151 2/20 0.48
TP53 P04637 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12660084 0.81 NPC1 (0.62) CASP3SENP8SENP7SENP6L3MBTL1
SCHEMBL13889828 0.81 CASP3 (1.00) CASP3SENP8SENP7SENP6CHUK
SCHEMBL14914829 0.78 SMN1; SMN2 (0.55) CASP3SENP8SENP7SENP6L3MBTL1
SCHEMBL9987876 0.78 L3MBTL1 (0.50) CASP3SENP8SENP7SENP6L3MBTL1
SCHEMBL7433112 0.78 BCHE (0.58) CASP3SENP8SENP7SENP6L3MBTL1
SCHEMBL13606307 0.76 CASP3 (0.77) CASP3SENP8SENP7SENP6CHUK
SCHEMBL2642361 0.76 PDK2 (0.49) CASP3SENP8SENP7SENP6L3MBTL1
SCHEMBL1281643 0.76 NPC1 (0.64) CASP3SENP8SENP7SENP6L3MBTL1
SCHEMBL17071980 0.76 RAB9A (0.49) L3MBTL1PDK2ALDH1A1HSD17B10MAPT
SCHEMBL9520118 0.75 ESR1 (0.47) CASP3SENP8SENP7SENP6L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140225027-A1 Silver Containing Hydrosilylation Catalysts And Compositions Containing The Catalysts DOW CORNING CORPORATION 2014-08-14 US disclosed
US-20140187783-A1 Hafnium Containing Hydrosilylation Catalysts and Compositions Containing the Catalysts DOW CORNING CORPORATION 2014-07-03 US disclosed
EP-0760811-B1 IMIDAZOLE DERIVATIVES AS HISTAMINE RECEPTOR H3 MODULATORS INST NAT SANTE RECH MED (FR) 2009-11-18 EP disclosed
US-6248765-B1 ANTIINFLAMMATORY AGENTS; HYPOTENSIVE AGENTS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICAL (FR) 2001-06-19 US disclosed
WO-1996029315-A2 IMIDAZOLE DERIVATIVES AS HISTAMINE RECEPTOR H3 (ANT)AGONISTS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) 1996-09-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140225027-A1 Silver Containing Hydrosilylation Catalysts And Compositions Containing The Catalysts ALG8, GYPA, HIRA CASP3 4143/4885SENP8 4113/4885SENP7 4705/4885
US-20140187783-A1 Hafnium Containing Hydrosilylation Catalysts and Compositions Containing the Catalysts HIRA, HACL2, CROCC CASP3 4141/4885SENP8 4227/4885SENP7 4377/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.